“…The following mechanisms of action were suggested: 1) inhibition of memory retrieval, which was observed for other -agonists, such as Tyr-D-ArgPhe--Ala (Ukai et al, 1995a) and morphine (Saha et al, 1991); 2) modulation of normal animal response to fear or anxiety (Asakawa et al, 1998), similar to that elicited by morphine and DAMGO, which exert anxiolytic activity in rats (File and Rodgers, 1979;Motta and Brandao, 1993;Motta et al, 1995;Koks et al, 1999); and 3) inhibition of noradrenergic neurons, because an opposite effect was observed for the -receptor antagonist naloxone (Introini and Baratti, 1986). Intracerebroventricular administration of endomorphin-1 failed to inhibit the consolidation of conditioned defeat, whereas morphine was shown to impair the consolidation of newly acquired memories in rats and mice (Izquierdo, 1979;Introini et al, 1985;Castellano et al, 1994;Cestria and Castellano, 1997;Rudy et al, 1999). Again three possibilities were proposed: 1) the endomorphin-1 dose used was too low; 2) the time of exposure to endomorphin-1 was not long enough to develop consolidation; and 3) the interaction with the -receptor could result in secondary messenger cascade different from that activated by morphine.…”